002653 Share Price | Haisco Pharmaceutical Group Co., Ltd. Stock Analysis & Recommendation

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Poor long term growth as Net Sales has grown by an annual rate of 7.87% and Operating profit at 23.27% over the last 5 years

With a growth in Net Profit of 1089.85%, the company declared Outstanding results in Mar 26

With ROE of 15.84%, it has a very expensive valuation with a 5.14 Price to Book Value

Consistent Returns over the last 3 years

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

CNY 37,567 Million (Large Cap)

P/E

81.00

Industry P/E

Dividend Yield

0.79%

Debt Equity

0.06

Return on Equity

15.84%

Price to Book

7.75

Revenue and Profits:

Net Sales:

1,532 Million

(Quarterly Results - Jun 2026)

Net Profit:

297 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

5.69%

6 Months

21.67%

1 Year

11.41%

2 Years

93.28%

3 Years

168.79%

4 Years

266.25%

5 Years

252.96%

Haisco Pharmaceutical Group Co., Ltd. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

7.87%

EBIT Growth (5y)

23.27%

EBIT to Interest (avg)

7.17

Debt to EBITDA (avg)

2.06

Net Debt to Equity (avg)

0.22

Sales to Capital Employed (avg)

0.62

Tax Ratio

4.96%

Dividend Payout Ratio

115.19%

Pledged Shares

Institutional Holding

ROCE (avg)

5.07%

ROE (avg)

12.23%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

12.83

EV to EBIT

95.91

EV to EBITDA

71.85

EV to Capital Employed

12.20

EV to Sales

12.34

PEG Ratio

0.99

Dividend Yield

0.48%

ROCE (Latest)

12.72%

ROE (Latest)

15.84%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Dow Theory

Mildly Bearish

No Trend

OBV

Mildly Bearish

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2026 is 38.13% vs 20.26% in Jun 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2026 is 158.14% vs 58.92% in Jun 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,531.60",
          "val2": "1,108.80",
          "chgp": "38.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "296.50",
          "val2": "172.10",
          "chgp": "72.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "7.10",
          "val2": "8.30",
          "chgp": "-14.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.10",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "296.60",
          "val2": "114.90",
          "chgp": "158.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "139.40%",
          "val2": "96.20%",
          "chgp": "4.32%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 17.82% vs 11.08% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -44.32% vs 57.71% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4,346.40",
          "val2": "3,689.10",
          "chgp": "17.82%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "459.10",
          "val2": "406.60",
          "chgp": "12.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "32.80",
          "val2": "38.20",
          "chgp": "-14.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-5.30",
          "val2": "0.20",
          "chgp": "-2,750.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "259.60",
          "val2": "466.20",
          "chgp": "-44.32%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "40.40%",
          "val2": "41.20%",
          "chgp": "-0.08%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]